Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 43 results for "Mk 5172"

No Evidence of Pharmacokinetic Drug-Drug Interaction in Health...

EASL - The International Liver Congress 2015 50th annual Meeting of the European association for the Study of the Liver Vienna, austria april 22-26 Reported by Jules Levin EASL 2015 April 22-26 Vienna Austria William L. Marshall*1; Wendy W. National AIDS Treatment Advocacy Project, 1 month ago
Merck May Dent Gilead's Hepatitis C Sales Forbes.com, 3 weeks ago

DDW: Single daily pill knocks out HCV in prior nonresponders

0 Flares 0 Flares × AT DDW 2015 WASHINGTON (FRONTLINE MEDICAL NEWS) An investigational once-daily antiviral drug combination produced high rates of sustained viral responses after 12 or 16 weeks of therapy with or without ribavirin ...
 PM 3601 week ago

MSD Announces Results from its Pivotal Phase 3 C-EDGE Programme and C-SURFER trial, Both Demonstrating High Sustained Virologic Responses across Broad Range of Hepatitis C Patients

MSD has today announced the first presentation of data from the C-SURFER trial, the first to investigate an all-oral, once-daily, Ribavirin-Free Hepatitis C treatment regimen of grazoprevir (100mg) and elbasvir (50mg)[1] in treatment-nave and ...
 PharmiWeb3 weeks ago

Gilead, Merck And Achillion/J&J Square Off In An HCV 'Nuc'lear Showdown

12:33 PM ET | About: Gilead Sciences, Inc. (GILD), Includes: ACHN, JNJ, MRK by: Small Pharma Analyst Summary Comparison of 7-day monotherapy of Sovaldi vs MK-3682 (MRK) and ACH 3422 indicate a rate of viral clearance of Sovaldi > MK-3682 > ...
 Seeking Alpha1 month ago Dubious IP Makes Achillion Pharma A Stock To Avoid  Seeking Alpha1 month ago

Fitch: More Competitors Expected in the Hepatitis C and Cardiovascular Markets

NEW YORK & CHICAGO--(BUSINESS WIRE)-- An ongoing stream of clinical data pointing to good safety and efficacy for new hepatitis C therapies indicates that competition for the drugs made by Gilead and AbbVie will increase, according to Fitch Ratings' ...
 CNBC1 month ago
[x]  

New HCV Drugs new nukes-NS5A/Protease Inhibitors

Here is a link to the 100+ reports I filed of studies at EASL........ Association for the Study of the Liver Vienna, Austria April 22-26 The key stories & themes include the large global phase 3 study results from Merck as the FDA is expected to ...
 National AIDS Treatment Advocacy Project1 month ago

Merck HCV Nuk MK3682 7-Day Monotherapy

EASL - The International Liver Congress 2015 50th annual Meeting of the European association for the Study of the Liver Vienna, austria april 22-26 A Phase I/IIa Study Assessing 7-Day Dosing of MK-3682 (formerly IDX21437) in Subjects Infected ...
 National AIDS Treatment Advocacy Project1 month ago

Merck Seems Confident About New Launches

As expected, Merck s (NYSE:MRK) revenues declined during the first quarter of 2015. This was partially due to strengthening dollar and partially due to the impact of divestitures and competitive pressure. The company's cardiovascular division's ...
 Trefis1 month ago

Resistance Analysis of Virologic Failures in Hepatitis C Genotype 1-Infected Patients Treated With Grazoprevir + Elbasvir ± Ribavirin: the C-WORTHY Study

EASL - The International Liver Congress 2015 50th annual Meeting of the European association for the Study of the Liver Vienna, austria april 22-26 Reported by Jules Levin EASL 2015 April 22-26 Vienna Austria Stuart Black1; Irene Pak1; Paul ...
 National AIDS Treatment Advocacy Project1 month ago

Awards for March 2015

Federal Awards Adinoff, Bryon, NIH, Lidocaine as a Treatment for Cocaine Relapse and Craving, $195,768; Bai, Xiaoying, NIH, Role of Transcription Pausing in Hematopoietic Stem Cell Development, $354,487; Banerjee, Subhash, UT Arlington/NIH, Novel ...
 University of Texas2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less